Capvizr
THE DEAL, AT A GLANCE

Chai Discovery

From the announcement
01
MoleculesDrug research
Medicine development
What it doesChai Discovery builds AI models to accelerate pre-clinical drug discovery, predicting and reprogramming the interactions between molecules.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Who is involvedBacked by Scratch Chai Discovery is a SanFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedChai Discovery raised $400M Series C, announced 2026-07-14From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersChai Discovery's $400M Series C positions the company as a large AI & Machine Learning financing within a crowded trailing 30-day funding market, with round size rather…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Chai Discovery · Financing Record

Explore source-linked visual explanations for Chai Discovery. Unsupported claims are withheld while source review continues.

Record 8130 · Recorded date: 2026-07-14

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime